FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2158853057> ?p ?o ?g. }

• W2158853057 endingPage "9307" @default.
• W2158853057 startingPage "9299" @default.
• W2158853057 abstract "Abstract Abnormal dendritic cell differentiation and accumulation of immature myeloid suppressor cells (ImC) is one of the major mechanisms of tumor escape. We tested the possibility of pharmacologic regulation of myeloid cell differentiation using all-trans-retinoic acid (ATRA). Eighteen patients with metastatic renal cell carcinoma were treated with ATRA followed by s.c. interleukin 2 (IL-2). Eight healthy individuals comprised a control group. As expected, the cancer patients had substantially elevated levels of ImC. We observed that ATRA dramatically reduced the number of ImC. This effect was observed only in patients with high plasma concentration of ATRA (&gt;150 ng/mL), but not in patients with lower ATRA concentrations (&lt;135 ng/mL). Effects of ATRA on the proportions of different dendritic cell populations were minor. However, ATRA significantly improved myeloid/lymphoid dendritic cell ratio and the ability of patients' mononuclear cells to stimulate allogeneic T cells. This effect was associated with significant improvement of tetanus-toxoid–specific T-cell response. During the IL-2 treatment, the ATRA effect was completely eliminated. To assess the role of IL-2, specimens from 15 patients with metastatic renal cell carcinoma who had been treated with i.v. IL-2 alone were analyzed. In this group also, IL-2 significantly reduced the number and function of dendritic cells as well as T-cell function. These data indicate that ATRA at effective concentrations eliminated ImC, improved myeloid/lymphoid dendritic cell ratio, dendritic cell function, and antigen-specific T-cell response. ATRA treatment did not result in significant toxicity and it could be tested in therapeutic combination with cancer vaccines. (Cancer Res 2006; 66(18): 9299-307)" @default.
• W2158853057 created "2016-06-24" @default.
• W2158853057 creator A5005003137 @default.
• W2158853057 creator A5006385791 @default.
• W2158853057 creator A5010439148 @default.
• W2158853057 creator A5030296219 @default.
• W2158853057 creator A5041091140 @default.
• W2158853057 creator A5046273815 @default.
• W2158853057 creator A5046458062 @default.
• W2158853057 creator A5060651469 @default.
• W2158853057 creator A5065741078 @default.
• W2158853057 date "2006-09-15" @default.
• W2158853057 modified "2023-10-15" @default.
• W2158853057 title "<i>All-trans</i>-Retinoic Acid Improves Differentiation of Myeloid Cells and Immune Response in Cancer Patients" @default.
• W2158853057 cites W120764409 @default.
• W2158853057 cites W130028085 @default.
• W2158853057 cites W1505374702 @default.
• W2158853057 cites W1550111480 @default.
• W2158853057 cites W1550301398 @default.
• W2158853057 cites W1574072808 @default.
• W2158853057 cites W1585754595 @default.
• W2158853057 cites W1598162705 @default.
• W2158853057 cites W1774777288 @default.
• W2158853057 cites W1788753937 @default.
• W2158853057 cites W1877245175 @default.
• W2158853057 cites W1913322240 @default.
• W2158853057 cites W1915413180 @default.
• W2158853057 cites W1976465320 @default.
• W2158853057 cites W1982951034 @default.
• W2158853057 cites W1984700615 @default.
• W2158853057 cites W1989782526 @default.
• W2158853057 cites W1998259019 @default.
• W2158853057 cites W1998625070 @default.
• W2158853057 cites W2002801575 @default.
• W2158853057 cites W2004316987 @default.
• W2158853057 cites W2009427332 @default.
• W2158853057 cites W2015904992 @default.
• W2158853057 cites W2023389612 @default.
• W2158853057 cites W2023473473 @default.
• W2158853057 cites W2049497785 @default.
• W2158853057 cites W2066712513 @default.
• W2158853057 cites W2066982596 @default.
• W2158853057 cites W2068971398 @default.
• W2158853057 cites W2069446399 @default.
• W2158853057 cites W2087907018 @default.
• W2158853057 cites W2098136315 @default.
• W2158853057 cites W2102634344 @default.
• W2158853057 cites W2105137065 @default.
• W2158853057 cites W2115674896 @default.
• W2158853057 cites W2117576368 @default.
• W2158853057 cites W2122664628 @default.
• W2158853057 cites W2128646629 @default.
• W2158853057 cites W2132132140 @default.
• W2158853057 cites W2133197725 @default.
• W2158853057 cites W2134653497 @default.
• W2158853057 cites W2140187740 @default.
• W2158853057 cites W2152999044 @default.
• W2158853057 cites W2168200596 @default.
• W2158853057 cites W2170390714 @default.
• W2158853057 cites W2268913889 @default.
• W2158853057 cites W2323921384 @default.
• W2158853057 cites W2324180569 @default.
• W2158853057 cites W2327237185 @default.
• W2158853057 cites W2407345634 @default.
• W2158853057 cites W2461447842 @default.
• W2158853057 cites W4238270225 @default.
• W2158853057 cites W4240302341 @default.
• W2158853057 cites W4243918768 @default.
• W2158853057 cites W4252960011 @default.
• W2158853057 cites W4299657671 @default.
• W2158853057 cites W53792933 @default.
• W2158853057 cites W92934419 @default.
• W2158853057 doi "https://doi.org/10.1158/0008-5472.can-06-1690" @default.
• W2158853057 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1586106" @default.
• W2158853057 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16982775" @default.
• W2158853057 hasPublicationYear "2006" @default.
• W2158853057 type Work @default.
• W2158853057 sameAs 2158853057 @default.
• W2158853057 citedByCount "507" @default.
• W2158853057 countsByYear W21588530572012 @default.
• W2158853057 countsByYear W21588530572013 @default.
• W2158853057 countsByYear W21588530572014 @default.
• W2158853057 countsByYear W21588530572015 @default.
• W2158853057 countsByYear W21588530572016 @default.
• W2158853057 countsByYear W21588530572017 @default.
• W2158853057 countsByYear W21588530572018 @default.
• W2158853057 countsByYear W21588530572019 @default.
• W2158853057 countsByYear W21588530572020 @default.
• W2158853057 countsByYear W21588530572021 @default.
• W2158853057 countsByYear W21588530572022 @default.
• W2158853057 countsByYear W21588530572023 @default.
• W2158853057 crossrefType "journal-article" @default.
• W2158853057 hasAuthorship W2158853057A5005003137 @default.
• W2158853057 hasAuthorship W2158853057A5006385791 @default.
• W2158853057 hasAuthorship W2158853057A5010439148 @default.
• W2158853057 hasAuthorship W2158853057A5030296219 @default.
• W2158853057 hasAuthorship W2158853057A5041091140 @default.
• W2158853057 hasAuthorship W2158853057A5046273815 @default.

• next